Advances in understanding monoclonal gammopathy of undetermined significance as a precursor of multiple myelomaThe use of novel oral anticoagulants for thromboprophylaxis after elective major orthopedic surgeryRisk factors for etiology and prognosis of mantle cell lymphomaMolecular prognostic factors in cytogenetically normal acute myeloid leukemiaPathogenesis and classification of eosinophil disorders: a review of recent developments in the fieldIron chelation therapy in myelodysplastic syndromes: where do we stand?Prognosis and management of acute myeloid leukemia in patients with Down syndromeThe PIM kinases in hematological cancersFertility issues following hematopoietic stem cell transplantationAcute erythroleukemia: diagnosis and managementDiffuse Large B-cell Lymphoma in the elderly: standard treatment and new perspectives.Management of lower-risk myelodysplastic syndromes without del5q: current approach and future trends.Diagnosis and management of catastrophic antiphospholipid syndrome.When to treat patients with relapsed follicular lymphoma.Large granular lymphocytic leukemia. Current diagnostic and therapeutic approaches and novel treatment options.Anemia in the elderly: a consequence of aging?Triplet combinations in relapsed/refractory myeloma: update on recent phase 3 trials.Typhlitis (neutropenic enterocolitis) in patients with acute leukemia: a review.The current state of adverse event reporting in hemophilia.Systemic therapy for cutaneous T-cell lymphoma: who, when, what, and why?How ruxolitinib modified the outcome in myelofibrosis: focus on overall survival, allele burden reduction and fibrosis changes.Thrombocytopenia and infections.Mature aggressive B-cell lymphoma across age groups - molecular advances and therapeutic implications.Diagnostic, prognostic and therapeutic role of CD30 in lymphoma.Decision points in the treatment of transfusional iron overload in patients with myelodysplastic syndromes: why, when, and how to chelate.Nelarabine in the treatment of pediatric and adult patients with T-cell acute lymphoblastic leukemia and lymphoma.How could patient reported outcomes improve patient management in chronic myeloid leukemia?Management of elderly and unfit patients with chronic lymphocytic leukemia.Can we prevent venous thrombosis with statins: an epidemiologic review into mechanism and clinical utility.Primary plasma cell leukemia 2.0: advances in biology and clinical management.Pica as a manifestation of iron deficiency.Postpartum haemorrhage: prevention and treatment.Epidemiology and treatment of relative anemia in children with sickle cell disease in sub-Saharan Africa.The shrinking role of chemotherapy in the treatment of chronic lymphocytic leukemia.Novel perspectives on diagnosis and clinical significance of the post-thrombotic syndrome in children.Established and emerging targeted therapies in the myelodysplastic syndromes.Reappraising the timing of transplant for indolent non-Hodgkin lymphomas.Present day management of inherited bleeding disorders in pregnancy.The role of proteasome inhibition in the treatment of malignant and non-malignant hematologic disorders.Richter transformation of CLL.
P1433
Q24619589-E6BEFE97-448D-48F1-A649-158E985CB8CBQ26828439-2D414BE9-26D7-46E0-BBBE-9B2C13C6826DQ26858960-43449456-18C7-4C3F-B624-7E3604292694Q26998811-B73CEB7B-B32C-4699-A826-8908A5CD9B13Q27003331-58FEAF4C-CFE9-435E-B63A-E7C4FADB187EQ27011747-4E05FEE6-E0F5-438D-AB25-9A872A6DFCAEQ27016577-86B0E23E-613F-4778-99AF-A973EBD4FE3FQ28258028-0D89BDCC-4566-4D38-BE69-ADA5061B8E4FQ28297647-6A05566D-6AFD-4954-895B-8B006FF3AC57Q28298763-678F5A7D-EADD-497C-88B9-E0188C9AEAA8Q30235296-5451FC4E-FD07-43E1-B480-690D1EAFEE2EQ30235355-EAE05274-FE38-4FC1-B54E-9C7C0363EA8FQ30235356-6B798127-5CF6-442F-88A5-88C4AA49BAB2Q30238528-158574D8-FFFE-4333-822E-4BB898AB74DAQ30238757-5697D66A-B05B-4D00-8FCC-68B8DE86866CQ30238892-2FBBB566-600E-4E1B-BE35-76230C79037FQ30238893-7BC15863-3281-420D-BF1F-29566E035465Q30239073-4C703155-8DB2-4C08-BF15-33936AF9BDD6Q30239952-4A89761C-F84C-4EE3-A4A3-1FF9536FA214Q30239965-D9C220C8-59AB-42B9-9A6C-2538938E8543Q30240043-5673FC29-CBB2-4791-9C01-A82B71C9A4D3Q30240119-E6E668CE-593C-4A2E-97C4-4F7F57A8D4BFQ30240133-3DAD3308-B6B1-43B7-852D-37F2B65017E1Q30240160-A6DD0BB6-62D1-47A2-8069-9417044171B4Q30240190-82F94997-9BCF-4E8C-BC0E-3D20A0C09CF3Q30240892-CFB4E6DF-F40A-4831-973B-6BA6FFDECDFBQ30241092-CFE3DE10-22BB-4182-9E7E-0D8783AEA4C3Q30243914-E69B79F8-FDD4-4361-8185-56F08FD80018Q30243926-86110EFF-C49C-45AD-B994-95DAD94E47E4Q30243927-5170F905-A013-4E86-82FD-5707285DF18CQ30243934-9CD4D786-F2D7-40CC-B8D7-61A8A554F80EQ30243935-F0EDEE6A-50C2-4D7D-906A-B315B8F8292EQ30243937-8F1DEBEA-CDCC-4705-B29B-05B722C80295Q30243968-CB75C5CE-3F09-4740-A63A-60AA3B3B2193Q30245069-696612D2-B024-46A1-92C8-66BC1B41509BQ30245476-037FF971-05EF-42B4-9244-E74A131B4305Q30248407-E8A1FECD-EE7C-43E0-8E77-71A37C08D1EDQ30248782-40FB1B81-FE8E-416A-A391-4F421BE450D7Q30248842-34B78EB8-EB53-4CDC-8A1B-FBA2EAFB3456Q30249283-0D9478A0-24D2-4E60-A3C9-F6E9CF5775D0
P1433
description
journal
@en
revista científica
@es
rivista scientifica
@it
vědecký časopis
@cs
wetenschappelijk tijdschrift van Informa
@nl
wissenschaftliche Fachzeitschrift
@de
مجلة
@ar
वैज्ञानिक पत्रिका
@hi
name
Expert Review of Hematology
@ast
Expert Review of Hematology
@en
Expert Review of Hematology
@es
Expert Review of Hematology
@it
Expert Review of Hematology
@nl
type
label
Expert Review of Hematology
@ast
Expert Review of Hematology
@en
Expert Review of Hematology
@es
Expert Review of Hematology
@it
Expert Review of Hematology
@nl
prefLabel
Expert Review of Hematology
@ast
Expert Review of Hematology
@en
Expert Review of Hematology
@es
Expert Review of Hematology
@it
Expert Review of Hematology
@nl
P3181
P1055
P1058
P1156
19700174994
P1160
Expert Rev. Hematol.
P123
P1277
P1476
Expert Review of Hematology
@en
P236
P3181
P407
P571
2008-01-01T00:00:00Z